Size | Price | Stock | Qty |
---|---|---|---|
50mg |
|
||
100mg |
|
||
Other Sizes |
|
ln Vitro |
4'-Methoxychalcone (5 μM; 8 days) increases during adipocyte differentiation the mRNA expression of adipogenic genes, PPARγ, aP2, FAS, adiponectin, and GluT 4 substantially [1]. In preadipocyte 3T3-L1 cells, 4'-Methoxychalcone (5 μM; 8 days) decreases TNF-α-upregulated IL-6, PAI-1, and MCP-1 mRNA expression [1]. Increased PPARγ expression is caused during differentiation by 4'-Methoxychalcone (5 μM; 0-8 days), although C/EBPβ protein expression is mostly unaffected [1].
|
---|---|
Cell Assay |
RT-PCR[1]
Cell Types: Preadipocyte 3T3-L1 Cell Tested Concentrations: 5 μM Incubation Duration: 0 days; 2 days; 4 days; 6 days; 8 days Experimental Results: All adipogenic genes in adipocytes except GluT1 mRNA expression was increased. Western Blot Analysis[1] Cell Types: Preadipocyte 3T3-L1 Cell Tested Concentrations: 5 μM Incubation Duration: 8 days Experimental Results: PPARγ expression increased in adipocytes. |
References | |
Additional Infomation |
4'-Methoxychalcone is a member of chalcones.
|
Molecular Formula |
C16H14O2
|
---|---|
Molecular Weight |
238.28116
|
Exact Mass |
238.099
|
CAS # |
959-23-9
|
PubChem CID |
641818
|
Appearance |
White to light yellow solid powder
|
Density |
1.114g/cm3
|
Boiling Point |
397.5ºC at 760mmHg
|
Melting Point |
101-103 °C(lit.)
|
Flash Point |
180.5ºC
|
Index of Refraction |
1.606
|
LogP |
3.591
|
Hydrogen Bond Donor Count |
0
|
Hydrogen Bond Acceptor Count |
2
|
Rotatable Bond Count |
4
|
Heavy Atom Count |
18
|
Complexity |
282
|
Defined Atom Stereocenter Count |
0
|
SMILES |
COC1=CC=C(C=C1)C(=O)/C=C/C2=CC=CC=C2
|
InChi Key |
KJHHAPASNNVTSN-KPKJPENVSA-N
|
InChi Code |
InChI=1S/C16H14O2/c1-18-15-10-8-14(9-11-15)16(17)12-7-13-5-3-2-4-6-13/h2-12H,1H3/b12-7+
|
Chemical Name |
(E)-1-(4-methoxyphenyl)-3-phenylprop-2-en-1-one
|
HS Tariff Code |
2934.99.9001
|
Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
Solubility (In Vitro) |
DMSO : ~50 mg/mL (~209.84 mM)
|
---|---|
Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.5 mg/mL (10.49 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.  (Please use freshly prepared in vivo formulations for optimal results.) |
Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
1 mM | 4.1967 mL | 20.9837 mL | 41.9674 mL | |
5 mM | 0.8393 mL | 4.1967 mL | 8.3935 mL | |
10 mM | 0.4197 mL | 2.0984 mL | 4.1967 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration: mg/mL;
Method for preparing DMSO stock solution: mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation::Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O,mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.